TCE2 Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Celldex Therapeutics Inc

Watchlist Manager

Watchlist

Price: 32.44 EUR 6.05%

Market Cap: €2.1B

	Celldex Therapeutics Inc F:TCE2	US
A	Aurubis AG XMUN:NDA	DE
	Saudi Arabian Oil Co SAU:2222	SA
C	COSCO SHIPPING Development Co Ltd XHAM:EZ5	CN
	Konami Group Corp F:KOA0	JP
W	Weichai Power Co Ltd OTC:WEICF	CN
F	Franklin Resources Inc SWB:FRK	US
	Marcus Corp NYSE:MCS	US
W	Williams-Sonoma Inc F:WM1	US
P	PICC Property and Casualty Co Ltd XBER:PJC	CN
	TBS Holdings Inc TSE:9401	JP
	Foschini Group Ltd OTC:FHHGF	ZA
A	Allianz SE BMV:ALVN	DE

Profitability Summary

Celldex Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-35 688%

Negative 3Y Average Operating Margin

-7 449%

Declining Operating Margin

-3 720% > -35 688%

Negative Net Margin

-32 754%

Negative 3Y Average Net Margin

-6 693%

Declining Net Margin

-3 470% > -32 754%

Negative Free Cash Flow Margin

-26 126%

Negative 3Y Average Free Cash Flow Margin

-5 597%

Declining Free Cash Flow Margin

-3 506% > -26 126%

Negative ROE

-49%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-396%

Declining ROIC

-267% > -551%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.